NCT04878276

Brief Summary

Randomized, investigator-blinded, controlled, multicenter comparative study on the treatment of acute head lice infestation in children with 2 dimeticone preparations with different application times and compositions: Dimet 5® (100% dimeticone) versus Hedrin® Once Liquid Gel (4% dimeticone + nerolidol) with treatment success assessment via freedom from infestation of live head lice at final examination at V2, i.e. day 19 after first treatment.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
240

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2021

Longer than P75 for all trials

Geographic Reach
1 country

26 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 4, 2021

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 7, 2021

Completed
10 days until next milestone

Study Start

First participant enrolled

May 17, 2021

Completed
4.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2026

Completed
Last Updated

March 6, 2024

Status Verified

March 1, 2024

Enrollment Period

4.8 years

First QC Date

May 4, 2021

Last Update Submit

March 5, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Freedom from infestation

    Freedom from infestation of live head lice at the final examination (V2)

    Day 17 to 21

Study Arms (2)

Dimet 5

Dimet 5 is a certified medical device for the treatment of head lice infestation. It contains only ("liquid") dimeticone oil and, when used correctly, enables physical killing of head lice and their eggs.

Device: Dimet 5

Hedrin Once Liquid Gel

Hedrin Once Liquid Gel is a certified medical product for the removal of head lice and nits. The liquid gel contains 4% dimethicone and nerolidol (Penetrol®).

Device: Dimet 5

Interventions

Dimet 5DEVICE

The application is carried out according to the enclosed instructions for use.

Dimet 5Hedrin Once Liquid Gel

Eligibility Criteria

Age6 Months - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodProbability Sample
Study Population

Children ≥ 6 months with acute head lice infestation

You may qualify if:

  • Acute head lice infestation
  • Age ≥ 6 months
  • Adequate informed consent for study participation:
  • Age-appropriate informed consent and verbal informed consent from the patient (if capable of both).
  • Written informed consent from the legal guardian(s) (written and verbal).

You may not qualify if:

  • Adults (≥ 18 years of age)
  • Known hypersensitivity to any component of the test or comparator product.
  • Scalp lice therapy in the previous 2 weeks (with an appropriate drug or medical device).
  • Severe disease of the scalp or injuries/open wounds on the hairy head
  • Secondary infection in the area of the hairy head
  • Treatment with cotrimoxazole or trimethoprim in the last 4 weeks or new treatment to be initiated now
  • Simultaneous participation of another household member in the trial.
  • Previous participation in this trial
  • Participation in another trial within the last 30 days
  • Inability of the legal guardian(s) to understand the study content and instructions.
  • Limited legal capacity of the legal guardian(s)
  • Apparent unreliability or unwillingness to cooperate on the part of the legal guardian(s)
  • Known alcohol, medication or drug dependency of the legal guardian(s)
  • Dependence of the patient or guardian on the sponsor or investigator.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (26)

Dr. med. Thilo Heising

Aalen, Germany

ACTIVE NOT RECRUITING

Gemeinschaftspraxis Gilb/Bauer/von Bentzel

Augsburg, Germany

RECRUITING

Dr. med. Omar Esteban Fernandez Salgueiro

Balingen, Germany

ACTIVE NOT RECRUITING

Dr. med. Martin Wiesner

Berlin, Germany

WITHDRAWN

Praxis für Kinder- und Jugendheilkunde

Blankenfelde, Germany

RECRUITING

Gemeinschaftspraxis für Kinder- und Jugendmedizin

Bremen, Germany

RECRUITING

Kinderarztpraxis Vaitl

Chemnitz, Germany

RECRUITING

Praxis Dr. Glatzel

Düsseldorf, Germany

RECRUITING

Kinderarztpraxis Dr. Lichtenstein

Eschborn, Germany

RECRUITING

Kinderarztpraxis Dr. Zumegen

Essen, Germany

RECRUITING

Kinderärztliche Gemeinschaftspraxis Tost/Lange

Greifswald, Germany

RECRUITING

Gemeinschaftspraxis Dreher/Hübler

Guelders, Germany

RECRUITING

Dr. med. Friedrich Kaiser

Hamburg, Germany

ACTIVE NOT RECRUITING

Dr. med. Ludwig Stapenhorst

Hürth, Germany

RECRUITING

Kinderarztpraxis Dr. Hable

Leipzig, Germany

RECRUITING

Kinderärzte im Karree

Leverkusen, Germany

WITHDRAWN

Dr. med. Susanne Ludwig

Lübeck, Germany

WITHDRAWN

Kinderarztpraxis Dr. Bach

Mainz, Germany

RECRUITING

Dr. med. Katrin Biebach

München, Germany

ACTIVE NOT RECRUITING

Kinderarztpraxis am Ringmarkt

Neuwied, Germany

RECRUITING

Giraffenpraxis

Ratingen, Germany

RECRUITING

Kinderarztpraxis Dr. Steinmetz

Saarbrücken, Germany

RECRUITING

Kinderarztpraxis Dr. Klink

Schwarzenberg, Germany

RECRUITING

Simon Traub

Schweigen-Rechtenbach, Germany

ACTIVE NOT RECRUITING

Kinder- und Jugendarztpraxis

Weil am Rhein, Germany

RECRUITING

PediaMed Wolfsburg

Wolfsburg, Germany

RECRUITING

MeSH Terms

Conditions

Lice Infestations

Condition Hierarchy (Ancestors)

Ectoparasitic InfestationsSkin Diseases, ParasiticParasitic DiseasesInfectionsSkin Diseases, InfectiousSkin DiseasesSkin and Connective Tissue Diseases

Central Study Contacts

Beril Wachall

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 4, 2021

First Posted

May 7, 2021

Study Start

May 17, 2021

Primary Completion

March 1, 2026

Study Completion

March 1, 2026

Last Updated

March 6, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share

Locations